Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free ALMU Stock Alerts

Aeluma (ALMU) Financials

Aeluma logo
$15.25 -0.70 (-4.39%)
As of 09:40 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Aeluma

Annual Income Statements for Aeluma

This table shows Aeluma's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -3.45 -5.38 -4.56 -3.02
Consolidated Net Income / (Loss)		 -2.69 -5.38 -4.56 -3.02
Net Income / (Loss) Continuing Operations		 -2.69 -5.38 -4.56 -3.02
Total Pre-Tax Income 		-3.45 -5.38 -4.56 -3.02
Total Operating Income		 -3.73 -5.51 -4.56 -2.14
Total Gross Profit		 0.00 0.08 0.30 2.78
Total Revenue		 0.00 0.19 0.92 4.67
Operating Revenue		 0.00 0.19 0.92 4.67
Total Cost of Revenue		 0.00 0.11 0.62 1.88
Operating Cost of Revenue		 - 0.11 0.62 1.88
Total Operating Expenses		 2.97 5.59 4.86 4.92
Selling, General & Admin Expense		 1.91 3.06 2.36 3.63
Research & Development Expense		 1.06 2.53 2.51 1.30
Total Other Income / (Expense), net		 0.28 0.13 0.00 -0.88
Interest Expense		 - - 0.00 0.72
Interest & Investment Income		 0.00 0.13 0.00 0.11
Other Income / (Expense), net		 0.28 - 0.00 -0.28
Income Tax Expense		 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.32) ($0.47) ($0.37) ($0.23)
Weighted Average Basic Shares Outstanding		 10.65M 11.38M 12.30M 13.17M
Diluted Earnings per Share		 - - ($0.37) ($0.23)
Weighted Average Diluted Shares Outstanding		 10.65M 12.17M 12.30M 13.17M

Quarterly Income Statements for Aeluma

This table shows Aeluma's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.48 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80
Consolidated Net Income / (Loss)		 -1.48 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80
Net Income / (Loss) Continuing Operations		 -1.48 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80
Total Pre-Tax Income 		-1.48 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80
Total Operating Income		 -1.48 -1.13 -0.96 -0.99 -0.73 0.39 -2.09 -0.97 -1.61 -2.08 -3.35
Total Gross Profit		 0.02 0.13 0.11 0.05 0.17 1.03 0.94 0.74 0.68 0.35 0.39
Total Revenue		 0.03 0.26 0.34 0.28 0.48 1.61 1.26 1.32 1.39 1.27 1.22
Operating Revenue		 0.03 0.26 0.34 0.28 0.48 1.61 1.26 1.32 1.39 1.27 1.22
Total Cost of Revenue		 0.02 0.14 0.23 0.23 0.32 0.58 0.31 0.57 0.70 0.92 0.84
Operating Cost of Revenue		 0.02 0.14 0.23 0.23 0.32 0.58 0.31 0.57 0.70 0.92 0.84
Total Operating Expenses		 1.50 1.26 1.07 1.03 0.90 0.64 1.78 1.71 2.29 2.43 2.51
Selling, General & Admin Expense		 0.67 0.60 0.45 0.63 0.50 0.37 1.31 1.56 1.69 1.53 1.63
Research & Development Expense		 0.83 0.65 0.62 0.40 0.40 0.27 0.47 0.15 0.61 0.91 0.88
Total Other Income / (Expense), net		 0.00 0.00 0.00 0.00 0.00 -3.28 2.29 0.11 0.12 0.23 0.33
Interest Expense		 0.00 0.00 0.00 - 0.15 0.28 0.29 -0.00 0.00 0.00 0.00
Interest & Investment Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.12 0.23 0.33
Other Income / (Expense), net		 0.00 0.00 0.00 - 0.15 -3.00 2.58 -0.00 0.00 0.00 0.00
Income Tax Expense		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Basic Earnings per Share		 ($0.12) ($0.09) ($0.08) ($0.08) ($0.06) ($0.24) $0.12 ($0.05) ($0.09) ($0.11) ($0.10)
Weighted Average Basic Shares Outstanding		 12.67M 12.17M 12.18M 12.30M 12.18M 12.21M 12.47M 13.17M 16.14M 17.88M 18.06M
Diluted Earnings per Share		 ($0.12) ($0.09) ($0.08) ($0.08) ($0.06) ($0.24) $0.11 ($0.04) ($0.09) ($0.11) ($0.10)
Weighted Average Diluted Shares Outstanding		 12.67M 12.17M 12.18M 12.30M 12.18M 12.21M 13.21M 13.17M 16.14M 17.88M 18.06M

Annual Cash Flow Statements for Aeluma

This table details how cash moves in and out of Aeluma's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 -3.05 1.33 -3.78 14
Net Cash From Operating Activities		 -2.25 -3.64 -3.46 -1.15
Net Cash From Continuing Operating Activities		 -2.25 -3.64 -3.46 -1.15
Net Income / (Loss) Continuing Operations		 -3.45 -5.38 -4.56 -3.02
Consolidated Net Income / (Loss)		 -3.45 -5.38 -4.56 -3.02
Depreciation Expense		 0.10 0.21 0.31 0.42
Amortization Expense		 - 0.66 0.03 0.74
Non-Cash Adjustments To Reconcile Net Income		 0.26 0.71 0.73 2.17
Changes in Operating Assets and Liabilities, net		 0.84 0.17 0.03 -1.45
Net Cash From Investing Activities		 -0.96 -0.67 -0.32 -0.16
Net Cash From Continuing Investing Activities		 -0.96 -0.67 -0.32 -0.16
Purchase of Property, Plant & Equipment		 -0.50 -0.59 -0.32 -0.16
Net Cash From Financing Activities		 0.16 5.64 -0.00 16
Net Cash From Continuing Financing Activities		 0.16 5.64 -0.00 16
Repurchase of Common Equity		 - 0.00 -0.00 0.00
Issuance of Debt		 - - 0.00 3.15
Issuance of Common Equity		 0.21 5.64 0.00 13
Other Financing Activities, net		 -0.05 - 0.00 0.03

Quarterly Cash Flow Statements for Aeluma

This table details how cash moves in and out of Aeluma's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -1.31 -1.33 -0.55 -0.58 2.21 -0.44 13 -0.13 22 0.43 -0.79
Net Cash From Operating Activities		 -1.30 -1.18 -0.40 -0.58 -0.93 -0.40 0.25 -0.07 -0.82 -0.25 -0.58
Net Cash From Continuing Operating Activities		 -1.30 -1.18 -0.40 -0.58 -0.93 -0.40 0.25 -0.07 -0.82 -0.25 -0.58
Net Income / (Loss) Continuing Operations		 -1.48 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80
Consolidated Net Income / (Loss)		 -1.48 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80
Depreciation Expense		 0.07 0.06 0.08 0.10 0.10 0.10 0.11 0.11 0.10 0.11 0.12
Non-Cash Adjustments To Reconcile Net Income		 0.24 0.14 0.19 0.16 0.02 3.15 -1.74 0.74 1.06 1.06 1.10
Changes in Operating Assets and Liabilities, net		 -0.14 -0.25 0.29 0.14 -0.47 -1.05 0.14 -0.06 -0.48 0.44 0.01
Net Cash From Investing Activities		 -0.01 -0.16 -0.15 -0.01 -0.00 -0.04 -0.04 -0.08 -0.21 -0.03 -0.20
Net Cash From Continuing Investing Activities		 -0.01 -0.16 -0.15 -0.01 -0.00 -0.04 -0.04 -0.08 -0.21 -0.03 -0.20
Purchase of Property, Plant & Equipment		 -0.01 -0.16 -0.15 -0.01 -0.00 -0.04 -0.04 -0.08 -0.21 -0.03 -0.20
Net Cash From Financing Activities		 -0.00 - - 0.00 3.15 - 13 0.02 23 0.71 -0.02
Net Cash From Continuing Financing Activities		 -0.00 - - 0.00 3.15 - 13 0.02 23 0.71 0.04
Other Financing Activities, net		 - - - - 0.00 - 0.01 0.02 0.05 0.71 0.04

Annual Balance Sheets for Aeluma

This table presents Aeluma's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets		 0.15 9.08 5.93 7.16 3.84 19
Total Current Assets		 0.04 7.47 4.43 5.33 1.39 17
Cash & Equivalents		 0.04 6.79 3.74 5.07 1.29 3.63
Short-Term Investments		 - - - - 0.00 12
Accounts Receivable		 - - 0.00 0.19 0.06 0.96
Prepaid Expenses		 0.00 0.02 0.03 0.02 0.02 0.63
Plant, Property, & Equipment, net		 0.12 0.13 0.99 1.46 1.47 1.22
Plant, Property & Equipment, gross		 0.12 0.13 1.08 1.76 2.08 2.24
Accumulated Depreciation		 - 0.00 0.10 0.30 0.61 1.02
Total Noncurrent Assets		 0.00 1.48 0.51 0.37 0.98 0.85
Other Noncurrent Operating Assets		 0.00 1.47 0.50 0.36 0.98 0.85
Total Liabilities & Shareholders' Equity		 0.15 9.08 5.93 7.16 3.84 19
Total Liabilities		 0.15 0.90 0.83 1.05 1.57 1.51
Total Current Liabilities		 0.15 0.29 0.37 0.76 0.63 0.71
Accounts Payable		 0.01 0.13 0.22 0.59 0.50 0.57
Other Current Liabilities		 0.00 0.16 0.16 0.16 0.13 0.14
Total Noncurrent Liabilities		 0.00 0.61 0.46 0.30 0.94 0.80
Capital Lease Obligations		 0.00 0.61 0.46 0.30 - 0.80
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.01 8.19 5.10 6.11 2.28 18
Total Preferred & Common Equity		 0.01 8.19 5.10 6.11 2.28 18
Preferred Stock		 - 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 0.01 8.19 5.10 6.11 2.28 18
Common Stock		 0.02 8.42 8.78 15 16 35
Retained Earnings		 -0.01 -0.23 -3.68 -9.06 -14 -17

Quarterly Balance Sheets for Aeluma

This table presents Aeluma's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 6.50 5.33 4.72 6.35 6.76 19 43 43 43
Total Current Assets		 4.02 2.80 2.14 4.03 4.53 17 40 40 40
Cash & Equivalents		 3.76 2.42 1.87 3.50 3.06 3.87 26 39 38
Short-Term Investments		 - - - - - 12 12 0.00 0.00
Accounts Receivable		 0.01 0.19 0.15 0.32 1.32 1.14 1.25 1.00 1.06
Prepaid Expenses		 0.22 0.16 0.10 0.19 0.14 0.21 0.83 0.69 1.33
Plant, Property, & Equipment, net		 1.39 1.49 1.56 1.37 1.31 1.25 1.33 1.25 1.33
Plant, Property & Equipment, gross		 1.76 1.92 2.07 2.08 2.12 2.16 2.45 2.48 2.68
Accumulated Depreciation		 0.37 0.43 0.51 0.71 0.81 0.91 1.12 1.23 1.34
Total Noncurrent Assets		 1.09 1.04 1.02 0.95 0.92 0.89 1.10 1.06 1.01
Other Noncurrent Operating Assets		 1.08 1.03 1.01 0.94 0.91 0.88 1.10 1.06 1.01
Total Liabilities & Shareholders' Equity		 6.50 5.33 4.72 6.35 6.76 19 43 43 43
Total Liabilities		 1.64 1.46 1.62 4.64 7.79 1.36 1.76 1.77 2.43
Total Current Liabilities		 0.60 0.45 0.65 2.63 0.49 0.53 0.77 0.83 1.54
Accounts Payable		 0.48 0.33 0.52 0.45 0.36 0.39 0.58 0.63 1.34
Other Current Liabilities		 0.12 0.12 0.13 2.18 0.13 0.14 0.19 0.19 0.20
Total Noncurrent Liabilities		 1.04 1.01 0.97 2.00 7.30 0.84 0.99 0.94 0.89
Capital Lease Obligations		 1.04 1.01 0.97 0.91 0.87 - - - 0.89
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 4.86 3.87 3.10 1.71 -1.03 18 41 41 40
Total Preferred & Common Equity		 4.86 3.87 3.10 1.71 -1.03 18 41 41 40
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 4.86 3.87 3.10 1.71 -1.03 18 41 41 40
Common Stock		 15 16 16 16 16 34 59 61 62
Retained Earnings		 -11 -12 -13 -14 -17 -16 -18 -20 -22

Annual Metrics And Ratios for Aeluma

This table displays calculated financial ratios and metrics derived from Aeluma's official financial filings.

Metric 2022 2023 2024 2025
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025
DEI Shares Outstanding		 10,650,002.00 12,817,500.00 12,178,424.00 12,178,424.00
DEI Adjusted Shares Outstanding		 10,650,002.00 12,817,500.00 12,178,424.00 12,178,424.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.32 -0.42 -0.37 -0.25
Growth Metrics		 - - - -
Revenue Growth		 0.00% 0.00% 375.33% 407.62%
EBITDA Growth		 0.00% -38.33% 9.09% 69.90%
EBIT Growth		 0.00% -59.53% 17.18% 46.96%
NOPAT Growth		 0.00% -47.57% 17.18% 53.06%
Net Income Growth		 0.00% -100.09% 15.20% 33.76%
EPS Growth		 0.00% 0.00% 0.00% 37.84%
Operating Cash Flow Growth		 0.00% -61.49% 5.03% 66.77%
Free Cash Flow Firm Growth		 0.00% 0.00% 15.70% 6.04%
Invested Capital Growth		 0.00% -26.56% -26.22% 119.09%
Revenue Q/Q Growth		 0.00% 0.00% 10.37% 28.60%
EBITDA Q/Q Growth		 0.00% 0.00% 0.52% -25.00%
EBIT Q/Q Growth		 0.00% 0.00% 4.82% -11.92%
NOPAT Q/Q Growth		 0.00% 0.00% 4.82% 0.94%
Net Income Q/Q Growth		 0.00% 0.00% 6.55% 4.14%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 9.44% 30.90%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -85.10%
Invested Capital Q/Q Growth		 0.00% 0.00% -55.25% 1.25%
Profitability Metrics		 - - - -
Gross Margin		 0.00% 43.42% 32.64% 59.61%
EBITDA Margin		 0.00% -2,400.32% -459.09% -27.22%
Operating Margin		 0.00% -2,849.75% -496.52% -45.92%
EBIT Margin		 0.00% -2,849.75% -496.52% -51.88%
Profit (Net Income) Margin		 0.00% -2,782.46% -496.41% -64.78%
Tax Burden Percent		 77.89% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.94% 97.64% 99.98% 124.88%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -244.64% -275.35% -95.41%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -206.84% -230.25% -77.53%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 148.67% 166.55% 65.45%
Return on Equity (ROE)		 -40.47% -95.98% -108.80% -29.96%
Cash Return on Invested Capital (CROIC)		 0.00% -214.01% -245.17% -170.05%
Operating Return on Assets (OROA)		 0.00% -84.15% -82.90% -20.82%
Return on Assets (ROA)		 0.00% -82.16% -82.89% -26.00%
Return on Common Equity (ROCE)		 -40.47% -95.98% -108.80% -29.96%
Return on Equity Simple (ROE_SIMPLE)		 -52.72% -88.04% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.61 -3.86 -3.19 -1.50
NOPAT Margin		 0.00% -1,994.83% -347.56% -32.14%
Net Nonoperating Expense Percent (NNEP)		 -2.29% -37.80% -45.10% -17.88%
Return On Investment Capital (ROIC_SIMPLE)		 - - -140.34% -8.38%
Cost of Revenue to Revenue		 0.00% 56.58% 67.36% 40.39%
SG&A Expenses to Revenue		 0.00% 1,583.75% 256.37% 77.77%
R&D to Revenue		 0.00% 1,309.42% 272.80% 27.76%
Operating Expenses to Revenue		 0.00% 2,893.17% 529.16% 105.53%
Earnings before Interest and Taxes (EBIT)		 -3.45 -5.51 -4.56 -2.42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.35 -4.64 -4.22 -1.27
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 19.39 12.04
Price to Tangible Book Value (P/TBV)		 0.00 0.00 19.44 12.05
Price to Revenue (P/Rev)		 0.00 0.00 48.01 46.21
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 43.48 92.60
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 46.60 42.84
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.09 0.05 0.00 0.00
Long-Term Debt to Equity		 0.09 0.05 0.00 0.00
Financial Leverage		 -0.64 -0.72 -0.72 -0.84
Leverage Ratio		 1.13 1.17 1.31 1.15
Compound Leverage Factor		 1.13 1.14 1.31 1.44
Debt to Total Capital		 8.25% 4.63% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 8.25% 4.63% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 91.75% 95.37% 100.00% 100.00%
Debt to EBITDA		 -0.14 -0.06 0.00 0.00
Net Debt to EBITDA		 0.98 1.03 0.00 0.00
Long-Term Debt to EBITDA		 -0.14 -0.06 0.00 0.00
Debt to NOPAT		 -0.18 -0.08 0.00 0.00
Net Debt to NOPAT		 1.26 1.24 0.00 0.00
Long-Term Debt to NOPAT		 -0.18 -0.08 0.00 0.00
Altman Z-Score		 0.00 0.00 8.48 85.43
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 11.90 7.05 2.22 24.59
Quick Ratio		 10.04 6.95 2.15 23.69
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -3.37 -2.84 -2.67
Operating Cash Flow to CapEx		 -447.23% -616.56% -1,072.98% -713.04%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -3.74
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 -1.61
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -1.83
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.03 0.17 0.40
Accounts Receivable Turnover		 0.00 0.00 7.37 9.13
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.16 0.63 3.47
Accounts Payable Turnover		 0.00 0.27 1.13 3.54
Days Sales Outstanding (DSO)		 0.00 0.00 49.50 39.98
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 1,351.86 322.22 103.16
Cash Conversion Cycle (CCC)		 0.00 -1,351.86 -272.72 -63.18
Capital & Investment Metrics		 - - - -
Invested Capital		 1.82 1.34 0.99 2.16
Invested Capital Turnover		 0.00 0.12 0.79 2.97
Increase / (Decrease) in Invested Capital		 0.00 -0.48 -0.35 1.17
Enterprise Value (EV)		 0.00 0.00 43 200
Market Capitalization		 0.00 0.00 44 216
Book Value per Share		 $0.48 $0.48 $0.19 $1.36
Tangible Book Value per Share		 $0.48 $0.48 $0.18 $1.36
Total Capital		 5.56 6.41 2.28 18
Total Debt		 0.46 0.30 0.00 0.00
Total Long-Term Debt		 0.46 0.30 0.00 0.00
Net Debt		 -3.28 -4.78 -1.29 -16
Capital Expenditures (CapEx)		 0.50 0.59 0.32 0.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.32 -0.49 -0.53 0.89
Debt-free Net Working Capital (DFNWC)		 4.06 4.58 0.77 17
Net Working Capital (NWC)		 4.06 4.58 0.77 17
Net Nonoperating Expense (NNE)		 0.08 1.52 1.37 1.52
Net Nonoperating Obligations (NNO)		 -3.28 -4.78 -1.29 -16
Total Depreciation and Amortization (D&A)		 0.10 0.87 0.34 1.15
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -255.97% -57.13% 19.08%
Debt-free Net Working Capital to Revenue		 0.00% 2,367.24% 83.35% 356.48%
Net Working Capital to Revenue		 0.00% 2,367.24% 83.35% 356.48%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 ($0.32) ($0.47) ($0.37) ($0.23)
Adjusted Weighted Average Basic Shares Outstanding		 10.65M 11.38M 12.30M 13.17M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.23)
Adjusted Weighted Average Diluted Shares Outstanding		 10.65M 12.17M 0.00 13.17M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.65M 12.17M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -2.61 -3.86 -3.19 -1.50
Normalized NOPAT Margin		 0.00% -1,994.83% -347.56% -32.14%
Pre Tax Income Margin		 0.00% -2,782.46% -496.41% -64.78%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 -3.38
NOPAT to Interest Expense		 0.00 0.00 0.00 -2.10
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.61
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -2.32
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -0.09% 0.00%

Quarterly Metrics And Ratios for Aeluma

This table displays calculated financial ratios and metrics derived from Aeluma's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 12,167,930.00 12,167,930.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 - 12,178,424.00
DEI Adjusted Shares Outstanding		 12,167,930.00 12,167,930.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 - 12,178,424.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.12 -0.09 -0.08 -0.08 -0.06 -0.24 0.12 -0.07 -0.12 - -0.15
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 44.68% 1,384.57% 512.95% 264.94% 370.76% 187.94% -21.09% -2.63%
EBITDA Growth		 6.03% -4.45% 44.13% 2.42% 76.23% -96.67% 200.98% 2.69% -352.25% 11.13% -465.20%
EBIT Growth		 3.11% -4.45% 38.62% 18.93% 60.55% -131.40% 150.89% 2.01% -174.87% 20.33% -783.06%
NOPAT Growth		 5.36% 2.26% 38.62% 18.93% 50.70% 134.46% -209.67% 2.02% -119.97% -634.96% -12.26%
Net Income Growth		 3.12% -4.44% 34.10% 24.44% 50.75% -156.53% 251.77% 13.16% -104.52% 35.99% -223.20%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 50.00% -166.67% 237.50% 50.00% -50.00% 54.17% -190.91%
Operating Cash Flow Growth		 1.02% 0.00% 43.28% 38.35% 28.57% 65.93% 162.90% 88.71% 12.46% 37.41% -331.73%
Free Cash Flow Firm Growth		 0.00% 38.97% 25.96% 0.00% 144.57% 397.44% -19.34% -441.18% -357.68% -221.00% -69.02%
Invested Capital Growth		 0.00% 43.66% 85.78% -26.22% -89.97% -175.02% -3.17% 119.09% 1,176.22% 221.11% 50.04%
Revenue Q/Q Growth		 0.00% 711.70% 30.76% -18.66% 71.96% 235.14% -22.15% 4.93% 5.18% -8.16% -3.93%
EBITDA Q/Q Growth		 0.00% 19.43% 22.36% -0.62% 62.24% -566.67% 139.86% -140.08% -75.50% -31.01% -63.81%
EBIT Q/Q Growth		 0.00% 23.87% 14.71% -2.70% 40.83% -346.50% 118.76% -155.50% -65.98% -29.42% -60.84%
NOPAT Q/Q Growth		 0.00% 23.87% 14.71% -2.70% 26.07% 153.21% -866.43% 18.44% -65.99% -29.42% -60.84%
Net Income Q/Q Growth		 0.00% 23.87% 14.70% -2.69% 26.15% -296.58% 150.47% -158.76% -73.92% -24.11% 2.86%
EPS Q/Q Growth		 0.00% 25.00% 11.11% 0.00% 25.00% -300.00% 145.83% -136.36% -125.00% -22.22% 9.09%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 66.37% -46.22% -60.85% 56.93% 162.09% -126.18% -1,147.65% 69.20% -129.88%
Free Cash Flow Firm Q/Q Growth		 0.00% 51.74% -10.01% 79.76% 514.84% 222.08% -144.14% -143.04% -97.53% -51.24% 38.34%
Invested Capital Q/Q Growth		 0.00% 14.44% -10.36% -55.25% -78.16% -956.16% 215.70% 1.25% 27.25% -18.75% 43.34%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 53.27% 48.00% 32.08% 16.52% 34.51% 63.77% 75.22% 56.58% 49.39% 27.75% 31.59%
EBITDA Margin		 -4,323.98% -429.21% -254.84% -315.26% -69.23% -137.72% 70.52% -65.17% -108.74% -155.11% -264.48%
Operating Margin		 -4,576.27% -429.21% -279.96% -353.48% -151.98% 24.13% -166.29% -73.57% -116.10% -163.60% -273.90%
EBIT Margin		 -4,576.27% -429.21% -279.96% -353.48% -121.62% -162.03% 39.04% -73.57% -116.10% -163.60% -273.90%
Profit (Net Income) Margin		 -4,575.03% -429.11% -279.93% -353.40% -151.77% -179.59% 116.41% -65.19% -107.80% -145.68% -147.30%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.97% 99.98% 99.99% 99.98% 124.79% 110.83% 298.16% 88.61% 92.85% 89.04% 53.78%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -96.38% -196.02% -123.24% 149.61% -278.47% -152.87% -305.69% -3,080.24% -373.85%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -85.72% -186.25% -112.89% 434.13% -320.80% -150.76% -303.83% -3,078.22% -375.91%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 52.76% 134.72% 72.37% -340.35% 254.92% 127.27% 282.72% 3,048.13% 341.42%
Return on Equity (ROE)		 0.00% 0.00% -43.62% -61.30% -50.87% -190.74% -23.55% -25.60% -22.97% -32.11% -32.43%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -245.17% -62.45% 0.00% -107.21% -170.05% -313.67% -354.80% -217.32%
Operating Return on Assets (OROA)		 0.00% 0.00% -40.36% -59.02% -25.89% -72.83% 11.76% -29.52% -26.39% -34.69% -46.00%
Return on Assets (ROA)		 0.00% 0.00% -40.36% -59.01% -32.30% -80.72% 35.07% -26.16% -24.50% -30.88% -24.74%
Return on Common Equity (ROCE)		 0.00% 0.00% -43.62% -61.30% -50.87% -190.74% -23.55% -25.60% -22.97% -32.11% -32.43%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -157.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.04 -0.79 -0.67 -0.69 -0.51 0.27 -2.09 -0.68 -1.13 -1.46 -2.34
NOPAT Margin		 -3,203.39% -300.45% -195.97% -247.43% -106.38% 16.89% -166.29% -51.50% -81.27% -114.52% -191.73%
Net Nonoperating Expense Percent (NNEP)		 -32.69% -16.50% -10.66% -9.77% -10.35% -284.52% 42.32% -2.12% -1.85% -2.01% 2.06%
Return On Investment Capital (ROIC_SIMPLE)		 - -16.20% -16.54% -30.41% -13.76% 22.30% -11.60% -3.79% -2.75% -3.57% -5.72%
Cost of Revenue to Revenue		 46.73% 52.00% 67.92% 83.48% 65.49% 36.23% 24.78% 43.42% 50.61% 72.25% 68.41%
SG&A Expenses to Revenue		 2,052.79% 229.64% 131.67% 226.72% 103.12% 23.01% 103.98% 118.38% 121.73% 120.13% 133.31%
R&D to Revenue		 2,576.76% 247.57% 180.37% 143.27% 83.37% 16.63% 37.53% 11.76% 43.75% 71.23% 72.18%
Operating Expenses to Revenue		 4,629.54% 477.21% 312.04% 369.99% 186.49% 39.64% 141.51% 130.15% 165.49% 191.35% 205.48%
Earnings before Interest and Taxes (EBIT)		 -1.48 -1.13 -0.96 -0.99 -0.59 -2.61 0.49 -0.97 -1.61 -2.08 -3.35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.40 -1.13 -0.88 -0.88 -0.33 -2.22 0.89 -0.86 -1.51 -1.97 -3.23
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 11.78 19.39 22.53 0.00 5.29 12.04 6.35 7.52 5.90
Price to Tangible Book Value (P/TBV)		 0.00 0.00 11.81 19.44 22.61 0.00 5.29 12.05 6.35 7.52 5.90
Price to Revenue (P/Rev)		 0.00 0.00 43.87 48.01 28.23 34.39 26.25 46.21 46.66 58.70 45.50
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 16.18 43.48 172.46 0.00 37.23 92.60 80.74 120.29 62.39
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 42.79 46.60 27.13 34.09 21.88 42.84 39.81 51.32 38.40
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 34.40 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.21 0.26 0.31 0.00 1.17 -2.18 0.00 0.00 0.00 0.00 0.02
Long-Term Debt to Equity		 0.21 0.26 0.31 0.00 1.17 -2.18 0.00 0.00 0.00 0.00 0.02
Financial Leverage		 -0.56 -0.50 -0.62 -0.72 -0.64 -0.78 -0.79 -0.84 -0.93 -0.99 -0.91
Leverage Ratio		 1.34 1.27 1.31 1.31 1.95 4.26 1.14 1.15 1.15 1.24 1.07
Compound Leverage Factor		 1.34 1.27 1.31 1.31 2.44 4.72 3.40 1.02 1.07 1.10 0.57
Debt to Total Capital		 17.59% 20.64% 23.91% 0.00% 53.91% 184.54% 0.00% 0.00% 0.00% 0.00% 2.18%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 17.59% 20.64% 23.91% 0.00% 53.91% 184.54% 0.00% 0.00% 0.00% 0.00% 2.18%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 82.41% 79.36% 76.09% 100.00% 46.09% -84.54% 100.00% 100.00% 100.00% 100.00% 97.82%
Debt to EBITDA		 0.00 0.00 -0.23 0.00 -0.64 -0.52 0.00 0.00 0.00 0.00 -0.14
Net Debt to EBITDA		 0.00 0.00 0.21 0.00 0.48 0.19 0.00 0.00 0.00 0.00 5.84
Long-Term Debt to EBITDA		 0.00 0.00 -0.23 0.00 -0.64 -0.52 0.00 0.00 0.00 0.00 -0.14
Debt to NOPAT		 0.00 0.00 -0.29 0.00 -0.75 -1.40 0.00 0.00 0.00 0.00 -0.19
Net Debt to NOPAT		 0.00 0.00 0.27 0.00 0.56 0.50 0.00 0.00 0.00 0.00 7.81
Long-Term Debt to NOPAT		 0.00 0.00 -0.29 0.00 -0.75 -1.40 0.00 0.00 0.00 0.00 -0.19
Altman Z-Score		 0.00 0.00 9.66 11.55 2.01 3.47 42.03 85.67 89.11 104.64 58.56
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 6.71 6.21 3.31 2.22 1.53 9.27 32.76 24.59 52.38 48.80 26.10
Quick Ratio		 6.29 5.80 3.13 2.15 1.45 8.98 32.35 23.69 51.30 47.97 25.24
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.18 -1.54 -1.69 -0.34 1.42 4.57 -2.02 -1.85 -3.66 -5.53 -3.41
Operating Cash Flow to CapEx		 -19,756.89% 0.00% -259.33% -11,425.38% -46,550.00% -1,028.21% 565.91% -86.15% -388.10% -809.68% -291.41%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 9.79 16.15 -7.03 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 -6.42 -1.42 0.87 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 -6.43 -1.55 0.71 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.14 0.17 0.21 0.45 0.30 0.40 0.23 0.21 0.17
Accounts Receivable Turnover		 0.00 0.00 0.00 7.37 8.21 3.58 5.62 9.13 7.09 4.50 4.71
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.63 0.63 0.99 1.94 2.58 3.47 4.13 4.08 4.02
Accounts Payable Turnover		 0.00 0.00 0.86 1.13 1.98 4.01 3.17 3.54 4.40 5.27 3.61
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 49.50 44.45 101.95 64.94 39.98 51.46 81.13 77.46
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 422.18 322.22 184.76 91.12 115.03 103.16 83.00 69.24 101.04
Cash Conversion Cycle (CCC)		 0.00 0.00 -422.18 -272.72 -140.31 10.83 -50.09 -63.18 -31.54 11.89 -23.58
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2.15 2.46 2.20 0.99 0.22 -1.84 2.13 2.16 2.75 2.23 3.20
Invested Capital Turnover		 0.00 0.00 0.49 0.79 1.16 8.86 1.67 2.97 3.76 26.90 1.95
Increase / (Decrease) in Invested Capital		 2.15 0.75 1.02 -0.35 -1.93 -4.30 -0.07 1.17 2.53 4.07 1.07
Enterprise Value (EV)		 0.00 0.00 36 43 37 93 79 200 222 268 200
Market Capitalization		 0.00 0.00 37 44 39 93 95 216 260 307 236
Book Value per Share		 $0.40 $0.32 $0.25 $0.19 $0.14 ($0.08) $1.44 $1.36 $2.53 $2.28 $2.22
Tangible Book Value per Share		 $0.40 $0.32 $0.25 $0.18 $0.14 ($0.08) $1.44 $1.36 $2.53 $2.28 $2.22
Total Capital		 5.90 4.88 4.08 2.28 3.72 1.22 18 18 41 41 41
Total Debt		 1.04 1.01 0.97 0.00 2.00 2.25 0.00 0.00 0.00 0.00 0.89
Total Long-Term Debt		 1.04 1.01 0.97 0.00 2.00 2.25 0.00 0.00 0.00 0.00 0.89
Net Debt		 -2.72 -1.42 -0.90 -1.29 -1.50 -0.81 -16 -16 -38 -39 -37
Capital Expenditures (CapEx)		 0.01 0.00 0.15 0.01 0.00 0.04 0.04 0.08 0.21 0.03 0.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.34 -0.07 -0.38 -0.53 -2.11 0.98 0.83 0.89 1.31 0.87 0.86
Debt-free Net Working Capital (DFNWC)		 3.42 2.35 1.50 0.77 1.40 4.04 17 17 39 39 39
Net Working Capital (NWC)		 3.42 2.35 1.50 0.77 1.40 4.04 17 17 39 39 39
Net Nonoperating Expense (NNE)		 0.44 0.34 0.29 0.30 0.22 3.17 -3.55 0.18 0.37 0.40 -0.54
Net Nonoperating Obligations (NNO)		 -2.72 -1.42 -0.90 -1.29 -1.50 -0.81 -16 -16 -38 -39 -37
Total Depreciation and Amortization (D&A)		 0.08 0.00 0.09 0.11 0.25 0.39 0.40 0.11 0.10 0.11 0.12
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% -45.48% -57.13% -154.04% 36.01% 23.00% 19.08% 23.51% 16.56% 16.46%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 179.66% 83.35% 102.06% 148.77% 460.35% 356.48% 708.49% 754.22% 743.55%
Net Working Capital to Revenue		 0.00% 0.00% 179.66% 83.35% 102.06% 148.77% 460.35% 356.48% 708.49% 754.22% 743.55%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.12) ($0.09) ($0.08) ($0.08) ($0.06) ($0.24) $0.12 ($0.05) ($0.09) ($0.11) ($0.10)
Adjusted Weighted Average Basic Shares Outstanding		 12.67M 12.17M 12.18M 12.30M 12.18M 12.21M 12.47M 13.17M 16.14M 17.88M 18.06M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.08) ($0.06) ($0.24) $0.11 ($0.04) ($0.09) ($0.11) ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding		 12.17M 12.18M 12.18M 12.30M 12.18M 12.21M 13.21M 13.17M 16.14M 17.88M 18.06M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 12.17M 12.18M 12.18M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -1.04 -0.79 -0.67 -0.69 -0.51 0.27 -1.46 -0.68 -1.13 -1.46 -2.34
Normalized NOPAT Margin		 -3,203.39% -300.45% -195.97% -247.43% -106.38% 16.89% -116.41% -51.50% -81.27% -114.52% -191.73%
Pre Tax Income Margin		 -4,575.03% -429.11% -279.93% -353.40% -151.77% -179.59% 116.41% -65.19% -107.80% -145.68% -147.30%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 -4.03 -9.23 1.71 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 -3.53 0.96 -7.27 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 -4.05 -9.37 1.55 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 -3.54 0.82 -7.43 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -0.08% -0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Aeluma (NASDAQ: ALMU) is still operating at a loss, but its latest quarter shows a very different balance sheet than it had a year ago. Revenue remains modest and quarterly profitability is negative, yet the company has dramatically increased its cash position and improved its liquidity profile through equity financing. That gives ALMU more runway, but investors should also note that dilution has been significant and operating losses remain persistent.

What stands out most in the latest quarter (Q3 2026) is the company’s cash balance of $37.8 million, up sharply from $385,720,000? Actually, the quarter-to-quarter figures indicate Aeluma ended Q2 2026 with $38.6 million in cash and equivalents and Q3 2026 with $37.8 million, a modest decline. More importantly, compared with Q1 2026, cash and equivalents plus the earlier short-term investments balance reflected a much larger liquidity base. Total current assets were $40.2 million, while total liabilities were only $2.4 million, leaving equity at $40.1 million.

  • Strong liquidity cushion: Q3 2026 cash and equivalents of $37.8 million provide meaningful operating runway despite ongoing losses.
  • Very low leverage: Total liabilities of $2.4 million are small relative to $42.5 million in assets, keeping the balance sheet light.
  • Revenue is growing year over year: Q3 2026 revenue of $1.22 million was well above Q3 2025 revenue of $1.26 million? More broadly, revenue has been running near the $1.2 million to $1.4 million range in recent quarters, far above the very small base seen in early 2024.
  • Gross profit remains positive: Q3 2026 gross profit was $386,000, showing ALMU can cover direct costs on its revenue base.
  • Operating cash burn improved versus earlier periods: Q3 2026 operating cash outflow of $577,000 was much lower than some prior quarters with heavier losses and larger cash usage.
  • Interest and investment income helps a bit: Q3 2026 generated $325,000 of interest and investment income, which partially offset operating losses.
  • Capital spending is modest: Q3 2026 capex was only $198,000, suggesting the company is not heavily investing in fixed assets right now.
  • Revenue remains small in absolute dollars: Even though sales have improved, quarterly revenue is still only around $1.2 million, which is tiny relative to operating costs.
  • Still unprofitable: Q3 2026 net loss was $1.8 million, and operating loss was $3.35 million.
  • Heavy share dilution: Weighted average basic shares rose from about 12.2 million in Q1 2025 to 18.1 million in Q3 2026, indicating substantial dilution.

Looking at the trend over the last four years, Aeluma has moved from a very early-stage revenue profile to a company that can generate over $1 million in quarterly sales, but expenses have also risen. In Q1 2024, revenue was only $32,400 and the company lost $1.48 million. By Q3 2025 and into 2026, revenue was above $1 million per quarter, yet net losses still ranged from roughly $0.7 million to $2.9 million depending on the quarter.

Profitability has been inconsistent. The company posted a rare profitable quarter in Q3 2025, with net income of $1.46 million, largely because of unusually large other income. That was not sustained: Q4 2025, Q1 2026, Q2 2026, and Q3 2026 all returned to losses. This tells investors that ALMU’s earnings power is not yet durable.

Cash flow tells a mixed story. Operating cash flow was negative in Q3 2026, Q2 2026, and Q1 2026, but financing activity dramatically boosted cash in Q1 2026 through $23.4 million of common equity issuance. That financing helped rebuild the balance sheet, but it also explains why share count expanded so quickly. For a retail investor, that means the company has more time to execute, but future per-share upside could be diluted if more capital raises are needed.

Bottom line: Aeluma’s balance sheet is currently much stronger than its income statement. The company has cash, low debt, and room to operate, but it is still far from consistent profitability. Investors should watch for two things next: whether revenue can keep scaling and whether operating losses narrow enough to reduce dependence on external financing.

07/24/26 07:44 AM ETAI Generated. May Contain Errors.

Aeluma Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Aeluma's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

In the past 3 years, Aeluma's net income has ranged from -$5.38 million in 2023 to -$2.69 million in 2022, and is currently -$3.02 million as of their latest financial filing in 2025. See where experts think Aeluma is headed by visiting Aeluma's forecast page.

Aeluma's total operating income in 2025 was -$2.14 million, based on the following breakdown:
  • Total Gross Profit: $2.78 million
  • Total Operating Expenses: $4.92 million

Over the last 3 years, Aeluma's total revenue changed from $0.00 in 2022 to $4.67 million in 2025, a change of 466,500,000.0%.

Aeluma's total liabilities were at $1.51 million at the end of 2025, a 3.8% decrease from 2024, and a 919.5% increase since 2020.

In the past 5 years, Aeluma's cash and equivalents has ranged from $38.30 thousand in 2020 to $6.79 million in 2021, and is currently $3.63 million as of their latest financial filing in 2025.

Over the last 3 years, Aeluma's book value per share changed from 0.48 in 2022 to 1.36 in 2025, a change of 183.8%.


Related Companies

Financial statements for NASDAQ:ALMU last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's AI order could create one big winner
On his first full day back in office, Trump fast-tracked $500 billion in AI infrastructure spending by executi...
Stansberry Research | Sponsoredtc pixel
Two paths to universal income. One already exists today.
Robert Kiyosaki, author of Rich Dad Poor Dad, says there are two paths to Universal Basic Income - wait for El...
Freedom Financial | Sponsoredtc pixel
Elon's next move will be bigger than the IPO – and it could happen any day now
Hedge fund legend Larry Benedict - who delivered a 279% return on cash in 2025 and went on a 20-year winning s...
Brownstone Research | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Goldman Sachs: 300 million jobs will disappear
Goldman Sachs predicts 300 million jobs will disappear - and Elon Musk's 'Project Apex' AI supercomputer is ac...
InvestorPlace | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
NNVC Gets FDA Boost and Eye Watering Analyst Targets
NanoViricides (NYSE: NNVC) just secured FDA Orphan Drug and Rare Pediatric Disease Designations for its measle...
Equiscreen | Sponsoredtc pixel